Details for New Drug Application (NDA): 022502
✉ Email this page to a colleague
The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the adapalene profile page.
Summary for 022502
Tradename: | DIFFERIN |
Applicant: | Galderma Labs Lp |
Ingredient: | adapalene |
Patents: | 3 |
Suppliers and Packaging for NDA: 022502
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIFFERIN | adapalene | LOTION;TOPICAL | 022502 | NDA | Galderma Laboratories, L.P. | 0299-5912 | 0299-5912-01 | 15 mL in 1 BOTTLE (0299-5912-01) |
DIFFERIN | adapalene | LOTION;TOPICAL | 022502 | NDA | Galderma Laboratories, L.P. | 0299-5912 | 0299-5912-02 | 1 BOTTLE, PUMP in 1 CARTON (0299-5912-02) / 59 mL in 1 BOTTLE, PUMP |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Mar 17, 2010 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | May 31, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF ACNE | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 15, 2026 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF ACNE | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 15, 2026 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF ACNE |
Complete Access Available with Subscription